iSpecimen (ISPC) Share-based Compensation Growth (3y) (2023 - 2026)
iSpecimen (ISPC) Share-based Compensation Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 3.48% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -1.05% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 1.55% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 25.99% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 23.86% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -73.26% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -11.69% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 8.59% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -20.63% |
| 10 | iSpecimen | 658,857.59 | -2.16 Mn | 71,599.00 | -86.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -86.50% |
| Dec 31, 2025 | -66.06% |
| Sep 30, 2025 | -98.46% |
| Jun 30, 2025 | -25.99% |
| Mar 31, 2025 | -55.80% |
| Dec 31, 2024 | -60.03% |
| Sep 30, 2024 | -15.03% |
| Jun 30, 2024 | 43.14% |
| Mar 31, 2024 | 147.87% |
| Dec 31, 2023 | 106.56% |
| Sep 30, 2023 | 68.09% |
| Jun 30, 2023 | 84.94% |